Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
ASSETS
Cash and cash equivalents	$ 111,399	$ 121,845
Restricted cash	7,978	7,111
Accounts receivable, net of credit loss reserve of $6,349 and $6,827, respectively	274,311	312,174
Prepaid expenses and other current assets	32,612	26,304
Assets held for sale	0	7,480
Total current assets	426,300	474,914
Real estate and related assets:
Property and equipment, net of accumulated depreciation of $1,846,456 and $1,821,015, respectively	2,095,606	2,114,522
Other real estate assets	199,248	201,561
Goodwill	4,844	4,844
Other assets	301,360	309,558
Total assets	3,027,358	3,105,399
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable and accrued expenses	254,066	285,857
Current portion of long-term debt	110,487	11,597
Total current liabilities	364,553	297,454
Long-term debt, net	984,085	1,083,476
Deferred revenue	17,761	18,315
Non-current deferred tax liabilities	91,799	96,915
Other liabilities	125,237	131,673
Total liabilities	1,583,435	1,627,833
Commitments and contingencies
Preferred stock - $0.01 par value; 50,000 shares authorized; none issued and outstanding at March 31,2024 and December 31,2023, respectively	0	0
Common stock - $0.01 par value; 300,000 shares authorized; 111,568 and 112,733 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	1,116	1,127
Additional paid-in capital	1,742,111	1,785,286
Accumulated deficit	(299,304)	(308,847)
Total stockholders' equity	1,443,923	1,477,566
Total liabilities and stockholders' equity	$ 3,027,358	$ 3,105,399